Beta Cell Stress to Epitope Diversification: Post‐Translationally Modified Antigens in Type 1 Diabetes
Immunological Reviews · 2026
DOI: 10.1111/imr.70183 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2026. Verfasst von Megan L Proffer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Protein Processing, Post-Translational, Insulin-Secreting Cells, Autoantigens. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, National Institute of Allergy and Infectious Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Pancreatic beta cells are active participants in the loss of immune tolerance because their high secretory demand creates exceptional vulnerability to inflammatory exposure, endoplasmic reticulum (ER) stress, calcium dysregulation, and redox imbalance. These conditions can promote enzymatic and nonenzymatic changes in self‐proteins, generating post‐translationally modified (PTM) antigens and neoepitopes that were absent or poorly represented during immune tolerance. This review integrates the contributions with the broader type 1 diabetes (T1D) field to examine how beta cell stress, transglutaminase‐2 dependent reactions, peptidyl‐arginine deiminase mediated citrullination, oxidative modifications, and post‐translational peptide fusion reshape the antigenic landscape. We consider how these products alter antigen presentation and recognition by autoreactive T cells and how an evolving neoepitope repertoire may promote antigenic diversification and epitope spreading. Importantly, clonal recruitment of new determinants must be distinguished from apparent broadening caused by T cell receptor (TCR) cross‐reactivity, dual‐TCR expression, bystander activation, or tissue redistribution. Defining when modified epitopes arise, which are naturally presented, and which responses contribute to pathogenesis could improve biomarker development, patient stratification, and therapeutic strategies designed to reduce beta cell stress, thus enhancing survival and identity maintenance, while restoring immune tolerance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Endocrinology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID-Profile: Megan L Proffer, Saptarshi Roy, Jon D Piganelli
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- National Institute of Allergy and Infectious Diseases
- Breakthrough T1D (BT1D) through a Strategic Research Agreement (SRA)
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Proffer, M. L., Roy, S., & Piganelli, J. D. (2026). Beta Cell Stress to Epitope Diversification: Post‐Translationally Modified Antigens in Type 1 Diabetes. Immunological Reviews. https://doi.org/10.1111/imr.70183
Vancouver
Proffer ML, Roy S, Piganelli JD. Beta Cell Stress to Epitope Diversification: Post‐Translationally Modified Antigens in Type 1 Diabetes. Immunological Reviews. 2026. doi:10.1111/imr.70183
BibTeX
@article{Proffer2026,
author = {Proffer, Megan L and Roy, Saptarshi and Piganelli, Jon D},
title = {Beta Cell Stress to Epitope Diversification: Post‐Translationally Modified Antigens in Type 1 Diabetes},
journal = {Immunological Reviews},
year = {2026},
doi = {10.1111/imr.70183}
}
EUVIMED